Оценка эффективности лечения легочной гипертензии у детей с врожденными пороками сердца

Аннотация

Congenital heart defects (CHD) account for about 30% of all congenital malformations in children. So, high pulmonary hypertension (PH) on the one hand, reducing the quality of life of operated patients leads to early disability and premature death [1]. Still small and remains poorly studied dynamics of the regression of PH and medication reduction in the period of pre-operative preparation of patients to one or another correction of heart defects depending on weight and age. Therefore, revealing of laws of development of high PH in different types of CHD in children, development of rational tactics of medicament therapy, enhancing the quality of life and preparation for operational intervention when CHD are relevant in the modern pediatric service.